Applied Materials Inc (NASDAQ: AMAT) Is Getting Increasingly Hard To Ignore

Currently, there are 802.50M common shares owned by the public and among those 800.37M shares have been available to trade.

The company’s stock has a 5-day price change of -0.06% and 5.80% over the past three months. AMAT shares are trading -0.55% year to date (YTD), with the 12-month market performance down to -25.31% lower. It has a 12-month low price of $123.74 and touched a high of $255.89 over the same period. AMAT has an average intraday trading volume of 8.00 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.36%, 6.57%, and -6.49% respectively.

Institutional ownership of Applied Materials Inc (NASDAQ: AMAT) shares accounts for 80.69% of the company’s 802.50M shares outstanding.

It has a market capitalization of $129.80B and a beta (3y monthly) value of 1.66. The stock’s trailing 12-month PE ratio is 19.69, while the earnings-per-share (ttm) stands at $8.22. The company has a PEG of 2.27 and a Quick Ratio of 1.76 with the debt-to-equity ratio at 0.35. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.06% over the week and 2.61% over the month.

Earnings per share for the fiscal year are expected to increase by 9.88%, and 6.20% over the next financial year. EPS should shrink at an annualized rate of 8.69% over the next five years, compared to 24.62% over the past 5-year period.

Looking at the support for the AMAT, a number of firms have released research notes about the stock. TD Cowen stated their Buy rating for the stock in a research note on May 16, 2025, with the firm’s price target at $225-$220. Jefferies coverage for the Applied Materials Inc (AMAT) stock in a research note released on March 28, 2025 offered a Buy rating with a price target of $195. Edward Jones was of a view on March 12, 2025 that the stock is Buy, while KeyBanc Capital Markets gave the stock Overweight rating on January 17, 2025, issuing a price target of $225. Cleveland Research on their part issued Neutral rating on December 17, 2024.

Related Posts

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.